Showing results (51-60 of 136) with videos related to
Sort By:
Pageof 14
Plos One|January 12, 2018
Nano-Pulse Stimulation induces immunogenic cell death in human papillomavirus-transformed tumors and initiates an adaptive immune responseJoseph G Skeate, Diane M Da Silva, Elena Chavez-Juan, et al.Cancers|February 27, 2026
Targeting STAT3 Promotes Tumor Cell Death and Enhances T-Cell Activity in HPV16-Positive CancerRuben Prins, Daniel J Fernandez, Diane M Da Silva, et al.Cancer Research|March 1, 2005
Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptorJeffrey J Roszkowski, Gretchen E Lyons, W Martin Kast, et al.International Reviews of Immunology|May 12, 2011
Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancerLeonardo Mirandola, Martin J Cannon, Everardo Cobos, et al.Vaccine|May 6, 2006
Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsionPirouz Daftarian, Marc Mansour, Anita C Benoit, et al.Frontiers in Immunology|June 6, 2020
TNFSF14: LIGHTing the Way for Effective Cancer ImmunotherapyJoseph G Skeate, Mikk E Otsmaa, Ruben Prins, et al.Vaccine|December 17, 2009
Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stagesAndrew Gray, Maria de la Luz Garcia-Hernandez, Myrna van West, et al.The Prostate|April 27, 2011
Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancerMaurizio Chiriva-Internati, Yuefei Yu, Leonardo Mirandola, et al.Cancer Treatment Reviews|April 12, 2022
Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trialsBradley J Monk, Takayuki Enomoto, W Martin Kast, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 15, 2015
Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans CellsDiane M Da Silva, Andrew W Woodham, Paul H Naylor, et al.Pageof 14